Literature DB >> 19167607

An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.

S D Selcuklu1, M C Yakicier, A E Erson.   

Abstract

Various regions of amplification or loss are observed in breast tumors as a manifestation of genomic instability. To date, numerous oncogenes or tumor suppressors on some of these regions have been characterized. An increasing body of evidence suggests that such regions also harbor microRNA genes with crucial regulatory roles in cellular processes and disease mechanisms, including cancer. Here, we investigated 35 microRNAs localized to common genomic gain and/or loss regions in breast cancers. To examine amplification or loss of these microRNAs as a result of genomic instability, we performed semiquantitative duplex polymerase chain reaction in 20 breast cancer cell lines, 2 immortalized mammary cell lines, and 2 normal DNA controls. A comprehensive DNA fold number change data for 35 microRNA genes on chromosomal gain/loss regions are presented in breast cancer cells. A 23% (8/35) of the investigated microRNAs showed significant fold number increases (greater than fourfold) compared to GAPDH in one or more of the breast cell lines. Although no homozygous deletions were detected, fold number decreases indicating potential loss regions were observed for 26% (9/35) of the investigated microRNAs. Such fold number changes may point out some of these microRNAs as potential targets of the genomic instability regions as oncogene and tumor suppressor candidates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167607     DOI: 10.1016/j.cancergencyto.2008.09.009

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  miR-29b regulates migration of human breast cancer cells.

Authors:  Chen Wang; Zhen Bian; Da Wei; Jian-guo Zhang
Journal:  Mol Cell Biochem       Date:  2011-02-26       Impact factor: 3.396

2.  ALCAM is indirectly modulated by miR-125b in MCF7 cells.

Authors:  H Begum Akman; S Duygu Selcuklu; Mark T A Donoghue; Shiva Akhavantabasi; Aysegul Sapmaz; Charles Spillane; M Cengiz Yakicier; A Elif Erson-Bensan
Journal:  Tumour Biol       Date:  2014-12-25

3.  A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

Authors:  Hua Zhao; Jie Shen; Leonard Medico; Dan Wang; Christine B Ambrosone; Song Liu
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

4.  miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.

Authors:  Michael R Epis; Keith M Giles; Andrew Barker; Tulene S Kendrick; Peter J Leedman
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

5.  MicroRNA-21 Expression in Primary Breast Cancer Tissue Among Egyptian Female Patients and its Correlation with Chromosome 17 Aneusomy.

Authors:  Noura Ramadan Abdel-Hamid; Eman A Mohammed; Ashraf H Abbas; Fouad M Badr
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

6.  miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis.

Authors:  Beatriz A Walter; Gabriela Gómez-Macias; Vladimir A Valera; Mark Sobel; Maria J Merino
Journal:  J Cancer       Date:  2011-02-07       Impact factor: 4.207

7.  Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development.

Authors:  Fung-Yu Huang; Danny Ka-Ho Wong; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal:  Oncotarget       Date:  2015-10-27

8.  MicroRNA-124 enhances response to radiotherapy in human epidermal growth factor receptor 2-positive breast cancer cells by targeting signal transducer and activator of transcription 3.

Authors:  Ying Fu; Jianping Xiong
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

9.  Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.

Authors:  Bruna Sugita; Mandeep Gill; Akanskha Mahajan; Anju Duttargi; Saurabh Kirolikar; Rodrigo Almeida; Kenny Regis; Olusayo L Oluwasanmi; Fabio Marchi; Catalin Marian; Kepher Makambi; Bhaskar Kallakury; Laura Sheahan; Iglenir J Cavalli; Enilze M Ribeiro; Subha Madhavan; Simina Boca; Yuriy Gusev; Luciane R Cavalli
Journal:  Oncotarget       Date:  2016-11-29

10.  Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity.

Authors:  Jen-Wei Huang; Yemin Wang; Kiranjit K Dhillon; Philamer Calses; Emily Villegas; Patrick S Mitchell; Muneesh Tewari; Christopher J Kemp; Toshiyasu Taniguchi
Journal:  Mol Cancer Res       Date:  2013-10-02       Impact factor: 5.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.